Clinical trials
Completed Phase 2 Meibomian Gland Dysfunction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Azura Ophthalmics | 3 |
| Cloudbreak Therapeutics, LLC | 2 |
| Allergan | 1 |
| AxeroVision, Inc. | 1 |
| Hovione Scientia Limited | 1 |
| Kala Pharmaceuticals, Inc. | 1 |
| ORA, Inc. | 1 |
| Tarsus Pharmaceuticals, Inc. | 1 |
| Tehran University of Medical Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Meibomian Gland Dysfunction | 12 |
| Blepharitis | 2 |
| Dry Eye Syndromes | 2 |
| Mite Infestations | 1 |
| Pain | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.